Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03828929 · ClinicalTrials.gov registry record · Phase 3
Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock
A Phase 3 study, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT03828929 is a Phase 3 study that was terminated before completion, run by New York Presbyterian Brooklyn Methodist Hospital. The registered enrollment target is 3 participants.
The verdict
NCT03828929, a Phase 3 study, was terminated before completion, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
Preliminary studies show that giving a "cocktail" of intravenous vitamin C, vitamin B1, and steroids to critically ill patients with septic shock may dramatically improve mortality in those patients. These studies suffer from inadequate design due to lack of controls and blinding to prove the causal effect. Our goal is to conduct a prospective blinded randomized control trial to investigate whether this intervention truly effect outcomes.
Interventions
- DRUG Normal saline
- DRUG Vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-10-15 |
| Est. Completion | 2020-02-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03828929
The ClinicalTrials.gov registry entry for NCT03828929 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Presbyterian Brooklyn Methodist Hospital, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT03828929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03828929 about?
NCT03828929 is a clinical study titled "Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock". Preliminary studies show that giving a "cocktail" of intravenous vitamin C, vitamin B1, and steroids to critically ill patients with septic shock may dramatically improve mortality in those patients. These studies suffer from inadequate design due to lack of controls and blinding to prove the causal...
What is the current status of trial NCT03828929?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2019-10-15. Estimated completion is 2020-02-04.
What interventions are being tested in trial NCT03828929?
The interventions under investigation include: Normal saline (DRUG), Vitamin C (DRUG).
Who is sponsoring clinical trial NCT03828929?
This trial is sponsored by New York Presbyterian Brooklyn Methodist Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.